Drug Delivery System for Retinal Protection
update：2020-06-16
Features
Intravitreal injection of some drugs to treat retinal diseases has been successfully reported. However, there is a possibility of severe side effects, such as infection. So we have developed a transscleral drug delivery system by using non-biodegradable device, which enabled sustained drug delivery to the retina. Because of the nature of the device, we can deliver the multi-drug independently. We have performed our work in collaboration with Department of Bioengineering and Robotics.Targeted Application(s)/Industry
Using this drug delivery device, we may be able to apply our system not only to the retinal diseases but also to other diseases.For clinical application, we hope the collaboration with companies and organizations from the points of materials and original drug delivery to the focal regions.
Researchers
Division of Clinical Cell Therapy, Graduate School of Medicine
ABE Toshiaki
, Professor
MD
Keywords
Prev
List
Next